Differentiation between the Regulatory paths placed on Mouthwashes in the US and EU
Abstract
Regulating oral rinses has been and still is a topic of debate and confusion. Oral rinses are products that are mainly used for cleaning, perfuming and changing the appearance of the teeth, which in turn improves the individual’s external appearance. Adding medicinal ingredients to these rinses, it can then be used for the elimination and/or prevention of some oral diseases, an example being gingivitis. The United States Food and Drug Administration placed guidelines which state that mouthwashes with possible therapeutic properties should be registered as drugs rather than cosmetics. Meanwhile, on a different continent, Germany along with the other members of the European Union decided not to categorize mouthwashes as drugs, but rather as cosmetics, using its sole purpose of cleaning and beautifying the teeth as the excuse. The following research will thoroughly differentiate between the diverse regulatory systems forced upon mouthwashes across the two countries—the United States and Germany.
Downloads
References
https://www.trade.gov/topmarkets/pdf/Pharmaceuticals_Executive_Summary.pdf
2. Hall M, Hill D, Pave G. Global Pharmaceuticals 2016 industry statistics [Internet]. Hardman and Co.: London; 2017 Mar 02 [Cited 2018 Mar 25]. Available from:
http://www.hardmanandco.com/docs/default-source/sector-docs/life-sciences-documents/02.03.17-global-pharmaceutical-industry-2016-statistics.pdf
3. European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures (p4 & 7) [Internet]. EFPIA: Belgium; 2017 [Cited 2018 Mar 15]. Available from:
https://www.efpia.eu/media/219735/efpia-pharmafigures2017_statisticbroch_v04-final.pdf
4. Hanan MT and Freeman J. Structural Inertia and Organizational Change. American Sociological Review [Internet]. 1984 Apr [cited 2010 Mar 12]; 49(2):149-64. Available from:
http://www.jstor.org/stable/2095567
5. US Food & Drug Administration. Drugs @FDA Glossary of Terms. [Internet]. USFDA; 2017 Nov 14 [Cited 2018 Mar 11]. Available from:
https://www.fda.gov/drugs/informationondrugs/ucm079436.htm#D
6. European Medicines Agency. About the website, Glossary [Internet]. EMEA; 2018 [Cited 2018 Mar 10]. Available from:
http://www.ema.europa.eu/ema/index.jsp?curl=pages/document_library/landing/glossary.jsp&mid=&startLetter=M
7. Federal Institute for Drugs and Medical Devices. Medicinal Products: Evaluating benefit. Minimising risks [Internet].BfArm; 2013 [Cited 2018 Mar 13]. Available from:
https://www.bfarm.de/EN/Drugs/_node.html
8. US Food & Drug Administration. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?) [Internet]. USFDA; 2002 Jul 08 [updated 2012 Apr 30; cited 2018 Mar 15]. Available from:
https://www.fda.gov/Cosmetics/GuidanceRegulation/LawsRegulations/ucm074201.htm
9. US Food & Drug Administration. Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph [Internet]. Federal Register; 2003 May 29 [cited 2018 Mar 16]. Available from:
https://www.federalregister.gov/documents/2003/05/29/03-12783/oral-health-care-drug-products-for-over-the-counter-human-use-antigingivitisantiplaque-drug-products
10. US Food & Drug Administration. The Drug Development Process [Internet]. USFDA; 2018 Jan 04 [cited 2018 Mar 10]. Available from:
https://www.fda.gov/ForPatients/Approvals/Drugs/ucm405382.htm
11. US Food & Drug Administration. Drug Approval Process. [Internet]. USFDA [cited 2018 Mar 18]. Available from:
https://www.fda.gov/downloads/drugs/resourcesforyou/consumers/ucm284393.pdf
12. DR. G. Renner. Legislation of Cosmetics in the EU, Key Features of Regulation 1223/2009/EU (multiple pages) [Internet]. EU:2009 [cited 2018 Mar 19]. Available from:
https://www.cosmeticseurope.eu/files/6214/7643/4067/Key_features_of_the_CPR.pdf
13. Cosmetics Europe. Understanding the Cosmetics Regulation [Internet]. EU:2018 [cited 2018 Mar 11]. Available from:
https://www.cosmeticseurope.eu/cosmetics-industry/understanding-cosmetics-regulation/#
14. Cosmetics Europe (2015, March). From Cosmetics Europe guidelines on the product information file (P.I.F.) Requirement [Internet]. EU:2018 [cited 2018 Mar 11]. Available from:
https://www.cosmeticseurope.eu/download/cEw5VFdiMDh5VTB4cHh6OU9VRWo0QT09
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
